|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/43 | |||
| A61P 25/00 |
| (11) | Number of the document | 2830642 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13769624.1 |
| Date of filing the European patent application | 2013-03-14 | |
| (97) | Date of publication of the European application | 2015-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/031662 |
| Date | 2013-03-14 |
| (87) | Number | WO 2013/148277 |
| Date | 2013-10-03 |
| (30) | Number | Date | Country code |
| 201261618638 P | 2012-03-30 | US |
| (72) |
XIE, Hongsheng, US
FELICE, Brian, US
MCCAULEY, Thomas, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | SUBCUTANEOUS ADMINISTRATION OF IDURONATE- 2-SULFATASE |
| SUBCUTANEOUS ADMINISTRATION OF IDURONATE- 2-SULFATASE |